G
Gayle Bieler
Researcher at Research Triangle Park
Publications - 17
Citations - 1112
Gayle Bieler is an academic researcher from Research Triangle Park. The author has contributed to research in topics: SUDAAN & Poison control. The author has an hindex of 10, co-authored 17 publications receiving 1029 citations. Previous affiliations of Gayle Bieler include RTI International.
Papers
More filters
Journal ArticleDOI
Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data.
TL;DR: This paper shows how model-adjusted risks, risk differences, and risk ratio estimates can be obtained directly from logistic regression models in the complex sample survey setting to yield population-based inferences.
Journal ArticleDOI
Long-term evaluation of drug abuse resistance education☆
Susan T. Ennett,Dennis P. Rosenbaum,Robert L. Flewelling,Gayle Bieler,Christopher L. Ringwalt,Susan L. Bailey +5 more
TL;DR: Results from a longitudinal evaluation of the DARE program in 36 schools in Illinois provide only limited support for DARE's impact on student's drug use immediately following the intervention, and no support for either continued or emerging impact on drug use 1 or 2 years after receiving DARE instruction.
Journal ArticleDOI
Analysis of prevention program effectiveness with clustered data using generalized estimating equations.
TL;DR: This study demonstrates the generalized estimating equations (GEE) method, focusing specifically on the GEE-independent method, to control for within-cluster correlation in regression models with either continuous or binary outcomes.
Journal ArticleDOI
Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity.
Gayle Bieler,Rick Williams +1 more
TL;DR: Although the delta method approach is slightly more computationally intensive, small-sample simulations indicate that it has superior operating characteristics over the Poly-3 trend test of Bailer and Portier when background tumor incidence rates are low and survival patterns differ markedly across treatments.